BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Germ cell tumor AND SMAD4, JIP, Q13485, 4089, ENSG00000141646, MADH4, DPC4 AND Diagnosis
17 results:

  • 1. A rare case of neuroendocrine cell tumor mixed with a mucinous component in the ampulla of Vater.
    Sugai T; Uesugi N; Suzuki M; Suzuki N; Honda M; Abe T; Yanagawa N
    Diagn Pathol; 2024 Apr; 19(1):64. PubMed ID: 38678248
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Endoscopic Endonasal Approach to Intraconal Orbital tumors: Outcomes and Lessons Learned.
    Sindwani R; Sreenath SB; Recinos PF
    Laryngoscope; 2024 Jan; 134(1):47-55. PubMed ID: 37249188
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. [Advances of glioma biomarkers].
    Hao M; Liang Y; Guo R; Li X; Li Y; Wang L; Yu C; Yang Z
    Sheng Wu Gong Cheng Xue Bao; 2023 Apr; 39(4):1445-1461. PubMed ID: 37154316
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Integrated Genomic and Clinicopathologic Approach Distinguishes Pancreatic Grade 3 Neuroendocrine tumor From Neuroendocrine Carcinoma and Identifies a Subset With Molecular Overlap.
    Umetsu SE; Kakar S; Basturk O; Kim GE; Chatterjee D; Wen KW; Hale G; Shafizadeh N; Cho SJ; Whitman J; Gill RM; Jones KD; Navale P; Bergsland E; Klimstra D; Joseph NM
    Mod Pathol; 2023 Mar; 36(3):100065. PubMed ID: 36788102
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. smad4 haploinsufficiency in small intestinal neuroendocrine tumors.
    Hofving T; Elias E; Rehammar A; Inge L; Altiparmak G; Persson M; Kristiansson E; Johansson ME; Nilsson O; Arvidsson Y
    BMC Cancer; 2021 Jan; 21(1):101. PubMed ID: 33509126
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Overexpressed VEPH1 inhibits epithelial-mesenchymal transition, invasion, and migration of human cutaneous melanoma cells through inactivating the TGF-β signaling pathway.
    Feng H; Jia XM; Gao NN; Tang H; Huang W; Ning N
    Cell Cycle; 2019 Nov; 18(21):2860-2875. PubMed ID: 31599708
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Pancreatic High-Grade Neuroendocrine Neoplasms in the Korean Population: A Multicenter Study.
    Kim H; An S; Lee K; Ahn S; Park DY; Kim JH; Kang DW; Kim MJ; Chang MS; Jung ES; Kim JM; Choi YJ; Jin SY; Chang HK; Cho MY; Kang YK; Kang M; Ahn S; Kim YW; Hong SM;
    Cancer Res Treat; 2020 Jan; 52(1):263-276. PubMed ID: 31319641
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Mutational and copy number asset of primary sporadic neuroendocrine tumors of the small intestine.
    Simbolo M; Vicentini C; Mafficini A; Fassan M; Pedron S; Corbo V; Mastracci L; Rusev B; Pedrazzani C; Landoni L; Grillo F; Cingarlini S; Rindi G; Luchini C; Scarpa A; Lawlor RT
    Virchows Arch; 2018 Dec; 473(6):709-717. PubMed ID: 30219970
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. A Practical Approach to the Classification of WHO Grade 3 (G3) Well-differentiated Neuroendocrine tumor (WD-NET) and Poorly Differentiated Neuroendocrine Carcinoma (PD-NEC) of the Pancreas.
    Tang LH; Basturk O; Sue JJ; Klimstra DS
    Am J Surg Pathol; 2016 Sep; 40(9):1192-202. PubMed ID: 27259015
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Adenocarcinoma with sarcomatous dedifferentiation arising from mature cystic teratoma of the anterior mediastinum.
    Kim JY; Lee CH; Park WY; Kim JY; Kim AR; Shin N; Park DY; Huh GY
    Pathol Res Pract; 2012 Dec; 208(12):741-5. PubMed ID: 23089288
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Molecular classification of patients with unexplained hamartomatous and hyperplastic polyposis.
    Sweet K; Willis J; Zhou XP; Gallione C; Sawada T; Alhopuro P; Khoo SK; Patocs A; Martin C; Bridgeman S; Heinz J; Pilarski R; Lehtonen R; Prior TW; Frebourg T; Teh BT; Marchuk DA; Aaltonen LA; Eng C
    JAMA; 2005 Nov; 294(19):2465-73. PubMed ID: 16287957
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Immunohistochemistry as a tool in the differential diagnosis of ovarian tumors: an update.
    Baker PM; Oliva E
    Int J Gynecol Pathol; 2005 Jan; 24(1):39-55. PubMed ID: 15626916
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Pancreatic carcinoma in carriers of a specific 19 base pair deletion of CDKN2A/p16 (p16-leiden).
    de vos tot Nederveen Cappel WH; Offerhaus GJ; van Puijenbroek M; Caspers E; Gruis NA; De Snoo FA; Lamers CB; Griffioen G; Bergman W; Vasen HF; Morreau H
    Clin Cancer Res; 2003 Sep; 9(10 Pt 1):3598-605. PubMed ID: 14506146
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Hamartoma and lentiginosis syndromes: clinical and molecular aspects.
    Marsh DJ; Stratakis CA
    Front Horm Res; 2001; 28():167-213. PubMed ID: 11443851
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Hamartomatous polyposis syndromes: molecular genetics, neoplastic risk, and surveillance recommendations.
    Wirtzfeld DA; Petrelli NJ; Rodriguez-Bigas MA
    Ann Surg Oncol; 2001 May; 8(4):319-27. PubMed ID: 11352305
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Chromosome 18 deletions are common events in classical midgut carcinoid tumors.
    Löllgen RM; Hessman O; Szabo E; Westin G; Akerström G
    Int J Cancer; 2001 Jun; 92(6):812-5. PubMed ID: 11351300
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Carcinoid tumors of the extrahepatic bile ducts: a study of seven cases.
    Maitra A; Krueger JE; Tascilar M; Offerhaus GJ; Angeles-Angeles A; Klimstra DS; Hruban RH; Albores-Saavedra J
    Am J Surg Pathol; 2000 Nov; 24(11):1501-10. PubMed ID: 11075851
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.